Narrow search
Showing 1 - 10 of 308
Cover Image
Consequences of the TRIPS-Agreement for the provision of pharmaceuticals in developing countries
Oppermann, Julia - 2008
Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS … Arzneimittel gegen vernachlässigte Krankheiten bis zum 30.06.2008 überprüft. Unter Berücksichtigung des kurzfristigen …
Persistent link: https://www.econbiz.de/10009475357
Cover Image
The Shingo Prize for Operational Excellence: Rewarding World-Class Practices
Chakravorty, Satya S.; Atwater, J. Bryan; Herbert, James I. - 2008
Established in 1988, the Shingo Prize for Operational Excellence recognises organisations in the USA, Mexico and Canada …
Persistent link: https://www.econbiz.de/10009459022
Cover Image
Determinants of the Relations between Transitory Earnings and CEO Cash Compensation in the USA
Asthana, Sharad; Ye, Zhongxia Shelly - 2007
effect). This study has practical implications for regulators, corporations and investors, both in the USA and abroad. …
Persistent link: https://www.econbiz.de/10009459069
Cover Image
A study of outsourcing of premedia services to India by US companies
Nayak, Rahul P. - 2009
Offshore outsourcing continues to gain prominence as the printing industrystrides into the future. With different segments of the industry looking at reducingcosts and, in exchange providing value-added services, more companies turntowards outsourcing services offshore as a solution. Although it...
Persistent link: https://www.econbiz.de/10009459219
Cover Image
Auswirkungen von Medikamentengenehmigungen auf die Bewertung von Biotech- und Pharmaunternehmen: Eine Ereignisstudie. Eine empirische Untersuchung
Sturm, Andreas - 2006
Die Arbeit untersucht den Einfluss der Genehmigung von Medikamenten durch die amerikanische Zulassungsbehörde FDA (Food and Drug Administration) auf den Aktienkurs der Antrag stellenden Aktiengesellschaft. Dabei werden Genehmigungen von wichtigen pharmazeutischen und biopharmazeutischen...
Persistent link: https://www.econbiz.de/10009450191
Cover Image
Change agents and the evolution of the United States pharmaceutical industry, 1920--1960
Lee, Jeho - 1996
This dissertation examines the evolution of the market and the firms in the context of an emerging innovative race in the U.S. pharmaceutical industry. The history shows the existence of two distinct industry regimes. Before 1940, the industry can best be characterized as a competitive regime in...
Persistent link: https://www.econbiz.de/10009439017
Cover Image
Canada-India firm collaboration in health biotechnology
Ray, Monali; Thorsteinsdóttir, Halla - 2008
Strategic alliances are of critical importance to firms working in the health biotechnology2 field. Collaborations can provide firms with significant competitive advantages, shape their economic performance and help minimize risks in development activities (Hagedoorn, 1993). Alliances in the...
Persistent link: https://www.econbiz.de/10009475749
Cover Image
Human resource management and learning based on in-house R&D in a developing country context
Santiago, Fernando; Alcorta, Ludovico - 2009
This paper investigates the influence of human resource management practices on the likelihood that a firm performs in-house R&D. The latter is broadly interpreted as learning---a mechanism promoting absorptive capacity and supporting technology capability-building in latecomer firms. The use of...
Persistent link: https://www.econbiz.de/10009476008
Cover Image
Intellectual Property Rights Regime and Creation of Innovation Based Enterprises in India
Basant, Rakesh - 2006
pharmaceuticals- biotechnologysectors. It is built on the premise that ceteris paribus participation of Indian firms in IPcreation and …
Persistent link: https://www.econbiz.de/10009476130
Cover Image
Farmacijos pramonės etinės problemos
Broga, Mindaugas - 2010
Šiame darbe stengiamasi išanalizuoti farmacijos pramonės etines problemas ir pateikti galimus šių problemų sprendimo būdus bei ateities perspektyvas. Farmacijos produktų specifika nulemia farmacijos kompanijų moralinių ir socialinių pareigų visumą ir įpareigoja kompanijas ne tik...
Persistent link: https://www.econbiz.de/10009479276